Journal article icon

Journal article

Sero-efficacy of Vi-polysaccharide tetanus-toxoid typhoid conjugate vaccine (Typbar-TCV)

Abstract:
Background Salmonella Typhi is the major cause of enteric fever in lower income countries. New conjugate vaccines show promise as public health interventions, however there are no efficacy data available from endemic areas. Methods Data were obtained from a previously published phase 3 randomised controlled trial comparing Vi-polysaccharide tetanus-toxoid conjugate vaccine (Typbar-TCV; Bharat Biotech Intl Ltd, India): (Vi-TT) with Vi-polysaccharide (Typbar; ... Expand abstract
Publication status:
Published
Peer review status:
Peer reviewed
Version:
Accepted Manuscript

Actions


Access Document


Files:
Publisher copy:
10.1093/cid/cix1145

Authors


More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Primary Care; Primary Care Health Sciences
Oxford college:
All Souls College
ORCID:
0000-0001-6324-6559
More by this author
Institution:
University of Oxford
Division:
Medical Sciences Division
Department:
Paediatrics
Publisher:
Oxford University Press Publisher's website
Journal:
Clinical Infectious Diseases Journal website
Volume:
67
Issue:
1
Pages:
18–24
Publication date:
2018-01-17
Acceptance date:
2018-01-04
DOI:
EISSN:
1537-6591
ISSN:
1058-4838
Pubs id:
pubs:813759
URN:
uri:6f9bb884-3e7b-4f07-979d-c7c1db55720b
UUID:
uuid:6f9bb884-3e7b-4f07-979d-c7c1db55720b
Local pid:
pubs:813759

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP